AU2002313087A1 - Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
- Google Patents
Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002313087A
Inventor
Helene Coulomb
Christophe Lanco
Olivier Lavergne
Gregoire Prevost
Beng-Poon Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SASfiledCriticalSociete de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of AU2002313087A1publicationCriticalpatent/AU2002313087A1/en
AU2002313087A2001-05-302002-05-29Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
AbandonedAU2002313087A1
(en)
Pharmaceutical composition comprising derivatives of 2-biphenyl-4-yl-2,3-dihydro-1h-quinazolin-4-one and use thereof in the manufacture of medicaments for treating cancer and angiogenesis
Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment